RNA logoRNA
Avidity Biosciences Inc

1,625
Loading...
Loading...
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
391

Frequently Asked Questions

What is Market Cap of Avidity Biosciences Inc?
What is the 52-week high for Avidity Biosciences Inc?
What is the 52-week low for Avidity Biosciences Inc?
What is Avidity Biosciences Inc stock price today?
What was Avidity Biosciences Inc stock price yesterday?
What is the PE ratio of Avidity Biosciences Inc?
What is the Price-to-Book ratio of Avidity Biosciences Inc?
What is the 50-day moving average of Avidity Biosciences Inc?
How many employess does Avidity Biosciences Inc has?

Latest RNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.